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Background: The purpose of the study is to compare neointimal hyperplasia and
peristent arterial remodeling after implantation of everolimus-eluting stent (EES)
versus sirolimus-eluting stent (SES) using IVUS.
Methods: The study population was a subgroup of 293 patients from the EXCELLENT
trial, a randomized study comparing EES and SES for the treatment of de novo native
coronary artery lesions (total n=1,400, 3:1 randomization). There were 222 patients in
the EES group and 71 patients in the SES group in whom serial IVUS investigation
was performed at pre and post-PCI, and 9-month follow-up.
Results: Baseline clinical and angiographic characteristics were similar between the
two groups. At 9 months, percent neointimal volume obstruction did not differ between
EES and SES (2.67±4.14% vs. 2.27±4.37%, p=0.494). However, percent changes in
vessel volume (3.93±13.49% vs. 8.92±18.46%, p=0.038) and plaque+media (P&M)
volume (3.72±17.28% vs. 10.70±22.14%, p=0.017) within the stented segment were
smaller with EES versus SES. Positive persistent arterial remodeling defined as an
increase in vessel volume >10% (27.0% vs. 42.3%, p=0.015) and late acquired stent
malapposition (4.1% vs. 19.7%, p<0.001) were observed less frequently with EES
versus SES.
Conclusion: EES and SES were similarly effective in reducing neointimal hyperplasia.
However, positive persistent arterial remodeling and late acquired stent malapposition
occurred less frequently with EES.
TCT-686
Optical Coherence Tomography Assessment of Neointimal Coverage According
to the Presence Or Absence Of Malapposed Struts After Drug-eluting Stent
Implantation
Byeong-Keuk Kim, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang,
Myeong-Ki Hong
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University
College of Medicine, Seoul, Republic of Korea
Background: Although stent malapposition and incomplete neointimal coverage may
predispose to drug-eluting stents (DES) thrombosis, no data exists regarding the
relationship between the malapposed struts (MS) and uncovered struts (US) on optical
coherence tomography (OCT), especially depending on the extent or portions of
malapposition.
Methods: From Yonsei OCT registry, a total of 306 lesions in 271 patients after DES
implantation were grouped according to the presence of malapposition on follow-up
OCT and then divided into the 3 groups by the median value of % MS (1.3%); the
lesions without malapposition [Group I, (n=232)], with % MS<1.3% [Group II,
(n=37)], and ≥1.3% [Group III, (n=37)]. Percent MS and US were calculated as percent
ratio of MS or US to total struts in the defined cross-sections, respectively. We
compared each % US among these groups, according to the presence of MS.
Results: Group III showed a significantly higher % US in both whole struts and the
struts without malapposition, compared with other groups (See figure). Percent MS
significantly correlated with % US in the struts without malapposition (r=0.494,
p<0.001) as well as in the whole struts (r=0.618, p<0.001). These significant
correlations were only noted in the Group III.
Conclusion: This OCT study demonstrated that DES with malapposition, especially
with a higher % MS, showed a significantly higher incidence of US in the struts without
malapposition, as well as in the whole struts.
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Background: Confirming complete neointimal coverage after drug-eluting stents
(DES) implantation is clinically important, because incomplete stent coverage is the
significant predictor of late stent thrombosis. Previous study using optical coherence
tomography (OCT) demonstrated that stent struts of the first-generation DES still
remain uncovered at mid-term after deployment. On the other hand, 98% of the stent
struts were covered with uniform and thin neointima at 8 months after everolimus-
eluting stent (EES) implantation. However, the time-course up to 3 months analyses
of neointimal coverage in patients with EES (Xience V and PROMUS) has not been
reported. The aim of this study was to evaluate vessel responses at 1, 2 and 3 months
follow-up after EES implantation using OCT.
Methods: A total of 20 stents in 14 patients with de novo native coronary lesions were
enrolled in this study. OCT examination was performed at 1-month (n=7), 2-month
(n=10) and 3-month (n=3) follow-up after EES implantation. Cross-sectional OCT
images were analyzed at 1 mm intervals. The strut apposition to the vessel wall and
neointimal coverage on struts were evaluated by OCT. Mean neointimal hyperplasia
(NIH) thickness was also measured.
Results: The rate of neointimal coverage was 37%, 48% and 60% at 1, 2 and 3-month
follow-up after EES implantation, respectively (Table). The incidence of malapposition
was less than 1%. Intra-stent thrombus was observed in 3 stents among 20 stents.
Conclusion: This study showed that vessel healing was better with second-generation
DES within 3 months after implantation, suggesting that EES might have a favorable
vascular response in relatively early duration.
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Background: Late or very late stent thrombosis after drug-eluting stent (DES)
implantation may be related with incomplete neointimal coverage. Optical coherence
tomography (OCT) is valuable modality for the assessment of stent strut coverage. We
evaluated long-term (2 years) effect of everolimus-eluting stent (EES) for tissue
coverage and apposition of stents using OCT compared with 9 months follow-up
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